Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 2, 2026 | 7+ can't-miss Houston business and innovation events in June 2026 | Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add m... |
| May 20, 2026 | With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate | In the sprawling metropolis of Houston, a new biotech has emerged to tackle the biology underlying a lung disease that has no clear cause. Oorja Bio launched yesterday afternoon with $30 million and an in-licensed, novel approach to treat i... |
| May 20, 2026 | Oorja Bio Raises $30M in Series A Funding | Oorja Bio, Inc., a Houston, TX-based clinical-stage biopharmaceutical company, raised $30M in Series A funding. The round was led by Westlake BioPartners. The company intends to use the funds to advance the clinical development of ORJ-001, ... |
| Oorja Bio | “Oorja Bio's goal is to develop groundbreaking therapies for cardiopulmonary and fibrotic disorders that target the underlying pathophysiology of disease.” |
Reviews 0
FAQ about Oorja Bio Inc.
How much funding has Oorja Bio Inc. raised?
Oorja Bio Inc. has raised $30M in total across 1 funding round.
What has the press written about Oorja Bio Inc.?
Parsers VC has collected 5 articles mentioning Oorja Bio Inc., among them “7+ can't-miss Houston business and innovation events in June 2026” (Jun 2, 2026) and “With $30M launch, Oorja Bio breathes new life into South Korean fibrosis candidate” (May 20, 2026).
Is Oorja Bio Inc. still active?
Yes, Oorja Bio Inc. is active; its latest activity on Parsers VC dates from Jun 9, 2026.